Metabolic Approaches to Mental Health and Cognitive Decline
Christopher Palmer, MD
Founder and President, MH²; Founder and Director, Metabolic and Mental Health Program, McLean Hospital; Assistant Professor of Psychiatry, Harvard Medical School, Cambridge, MA.
Dr. Palmer has no financial relationships with companies related to this material.



_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.webp?t=1729528747)



